Table 2

HLM levels in donors’ and patients’ blood samples

mRNA isolated from cancer patients’ blood samples, collected before antitumor treatment, were amplified with primer sets for HLM and G3PDH genes and analyzed in an ethidium bromide-stained agarose gel. Samples positive or negative for HLM mRNA are indicated.
No.Tumor primary siteStageHistologyHLM RNA
 1LungLocalizedSmall cell +a
 2LungLocalizedAdenocarcinoma+
 3LungLocalizedSmall cell
 4LungLocalizedAdenocarcinoma
 5LungMetastaticAdenocarcinoma
 6LungMetastaticSmall cell+
 7LungMetastaticSquamous+
 8LungMetastaticSmall cell+
 9LungMetastaticSquamous
10LungINAINA
11ColonMetastaticRelapse+
12BreastMetastaticAdenocarcinoma
13BreastMetastaticRelapse
d1b
d2
d3
d4
d5
d6
d7
d8
d9
  • a +, detectable gene product; −, not detectable gene product; INA, information not available.

  • b d1–d9, tumor-free donors.